- Home
- ADBE vs BSX Comparison
ADBE vs BSX Comparison
Compare ADBE & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADBE
- BSX
- Stock Information
- Founded
- ADBE 1982
- BSX 1979
- Country
- ADBE United States
- BSX United States
- Employees
- ADBE N/A
- BSX N/A
- Industry
- ADBE Computer Software: Prepackaged Software
- BSX Medical/Dental Instruments
- Sector
- ADBE Technology
- BSX Health Care
- Exchange
- ADBE Nasdaq
- BSX Nasdaq
- Market Cap
- ADBE 136.1B
- BSX 146.2B
- IPO Year
- ADBE 1986
- BSX 1992
- Fundamental
- Price
- ADBE $319.28
- BSX $97.16
- Analyst Decision
- ADBE Buy
- BSX Strong Buy
- Analyst Count
- ADBE 23
- BSX 19
- Target Price
- ADBE $457.48
- BSX $124.53
- AVG Volume (30 Days)
- ADBE 3.4M
- BSX 7.9M
- Earning Date
- ADBE 12-10-2025
- BSX 10-22-2025
- Dividend Yield
- ADBE N/A
- BSX N/A
- EPS Growth
- ADBE 35.82
- BSX 54.68
- EPS
- ADBE 16.05
- BSX 1.87
- Revenue
- ADBE $23,181,000,000.00
- BSX $19,349,000,000.00
- Revenue This Year
- ADBE $12.33
- BSX $21.04
- Revenue Next Year
- ADBE $9.26
- BSX $11.45
- P/E Ratio
- ADBE $19.82
- BSX $51.88
- Revenue Growth
- ADBE 10.66
- BSX 21.61
- 52 Week Low
- ADBE $315.18
- BSX $85.98
- 52 Week High
- ADBE $557.90
- BSX $109.50
- Technical
- Relative Strength Index (RSI)
- ADBE 33.13
- BSX 39.63
- Support Level
- ADBE $323.03
- BSX $97.45
- Resistance Level
- ADBE $340.00
- BSX $105.65
- Average True Range (ATR)
- ADBE 6.67
- BSX 2.02
- MACD
- ADBE -1.24
- BSX -0.29
- Stochastic Oscillator
- ADBE 13.75
- BSX 11.12
About ADBE Adobe Inc.
Adobe provides content creation, document management, and digital marketing and advertising software and services to creative professionals and marketers for creating, managing, delivering, measuring, optimizing, and engaging with compelling content multiple operating systems, devices, and media. The company operates with three segments: digital media content creation, digital experience for marketing solutions, and publishing for legacy products (less than 5% of revenue).
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.